In all, these findings indicate that the homozygous and, to a lesser extent, heterozygous R136S mutation protects against APOE4-driven astrocytosis and microgliosis in the context of tauopathy in an age-dependent manner, which can lead to reduced hippocampal neurodegeneration and atrophy. The gene discussed is APOE; the disease is tauopathy.